-
公开(公告)号:JP2000191625A
公开(公告)日:2000-07-11
申请号:JP36247499
申请日:1999-12-21
Applicant: BASF AG
Inventor: KESSEL KNUT , KLUGE MICHAEL DR , GREINDL THOMAS DR , BOGENSTAETTER THOMAS DR , SCHERR GUENTER DR , RAULS MATTHIAS DR , VAN GELDER RICHARD
IPC: C07C277/08 , C07C279/14 , C07C303/22 , C07C309/15 , C07F9/38
Abstract: PROBLEM TO BE SOLVED: To readily obtain a guanidine derivative in a high purity, high yield and narrow particle size distribution by reacting O-alkyl isourea salt with a specific amine in the presence of a seed crystal of a guanidine derivative. SOLUTION: This guanidine derivative (A) is expressed by formula I [R1 is a 1-8C alkylene or a 5-10C bifunctional alicyclic group; R2 is H or a 1-8C alkyl; Z is COOR3, SO2R3 (R3 is H, an alkali metal or the like) or the like] and is obtained by reacting (B) an O-alkyl isourea salt of formula II (R5 is a 1-8C alkyl; X- is 1 equivalent of anion) with (C) an amine of formula III in the presence of (D) a seed crystal of a guanidine of formula I. Preferably, the reaction is performed in a reaction chamber in which the components B and C are continuously introduced and thereafter the crystal of the component D is continuously taken out.
-
公开(公告)号:JP2000229936A
公开(公告)日:2000-08-22
申请号:JP2000031893
申请日:2000-02-09
Applicant: BASF AG
Inventor: KESSEL KNUT , KLUGE MICHAEL DR , BOGENSTAETTER THOMAS DR , SCHERR GUENTER DR
IPC: C07C277/02 , C07C277/08 , C07C279/14
Abstract: PROBLEM TO BE SOLVED: To easily and continuously produce a guanidine derivative in a high purity and in a high yield by continuously reacting a cyanamide derivative with an amine in the presence of the seed crystals of the guanidine derivative. SOLUTION: This method for producing a guanamide derivative of formula III (R5, R6 are each H or a 1-8C alkyl) comprises continuously reacting a cyanamide derivative of formula I [R5', R6' are each H, the equivalent of an alkali(ne earth) metal or a 1-8C alkyl] with an amine of formula II R1 is a 1-8C alkylene or a 5-10C divalent alicyclic group; R2 is H or a 1-8C alkyl, or R1 and R2 form a Z-substituted five or six-membered ring together with the N atom bound to R1 and R2; and Z is COOR3 [R3 is H or the equivalent of an alkali(ne earth) metal] or the like) (for example, an amino carboxylic acid, an amino sulfonic acid or an amino phosphoric acid) in the presence of the seed crystals of the formula III. The cyanamide derivative of formula I and the amine of formula II are preferably used in a molar ratio of 2:1 to 1:2, and the reaction is carried out at pH 8-12 in an aqueous medium.
-
公开(公告)号:JP2000159742A
公开(公告)日:2000-06-13
申请号:JP33181799
申请日:1999-11-22
Applicant: BASF AG
Inventor: KLUGE MICHAEL DR , KESSEL KNUT , GREINDL THOMAS DR , BIEDERMANN NORBERT DR , SCHERR GUENTER DR , BOGENSTAETTER THOMAS DR
IPC: C07C273/18 , C07C273/00 , C07C275/70
Abstract: PROBLEM TO BE SOLVED: To obtain an O-alkyl isourea as an acid adduct salt in a high yield, if necessary, by dissolving and dispersing urea and an alkyl group donor in a diluent, followed by reacting them in a continuously operated reactor at a specific temperature. SOLUTION: An O-alkyl isourea shown by the formula (R1 is a 1-20C alkyl) is obtained as an acid adduct salt in a high yield, if necessary, by dissolving and dispersing (a) urea and (B) an alkyl group donor (e.g. dialkyl sulfate) in a diluent, followed by reacting them in a continuously operated reactor (e.g. continuously flowed column reactor and continuously stirred tank reactor) at 40-200 deg.C. It is preferable that an (A:B) molar ratio is (3:1)-(1:2). The diluent has a heat capacity which elevates the temperature of the reaction mixture maximally to 150 deg.oC or less upon performing a substantially adiabatic reaction by the heat of the reaction.
-
公开(公告)号:JP2000086616A
公开(公告)日:2000-03-28
申请号:JP25454399
申请日:1999-09-08
Applicant: BASF AG
Inventor: KESSEL KNUT DR , SCHERR GUENTER DR , KLUGE MICHAEL DR , BIEDERMANN NORBERT DR , GREINDL THOMAS DR , BOGENSTAETTER THOMAS DR , HAEHNLEIN WOLFGANG DR
IPC: C07C279/14 , C07C277/02 , C07C277/08
Abstract: PROBLEM TO BE SOLVED: To provide a simple and practicable method for producing creatine or creatine monohydrate without requiring great expenditures for measuring techniques or regulating techniques in regulating the value of pH using an inorganic acid or an organic acid. SOLUTION: The value of pH is regulated with carbonic acid in the case of a method for producing creatine or creatine monohydrate comprising reacting sodium sarcosinate or potassium sarcosinate with cyanamide at 20-150 deg.C temperature and 7.0-14.0 value of pH.
-
公开(公告)号:ES2172968T3
公开(公告)日:2002-10-01
申请号:ES99117237
申请日:1999-09-02
Applicant: BASF AG
Inventor: KESSEL KNUT DR , SCHERR GUNTER DR , KLUGE MICHAEL DR , BIEDERMANN NORBERT DR , GREINDL THOMAS DR , BOGENSTATTER THOMAS DR
IPC: C07C279/14 , C07C277/02 , C07C277/08
Abstract: Preparation of creatine or creatine monohydrate by reaction of sodium or potassium sarcosinate with cyanamide at 20-150 degrees C and pH 7.0 to 14.0, the pH value is obtained using carbonic acid.
-
公开(公告)号:DK0985661T3
公开(公告)日:2002-03-25
申请号:DK99117237
申请日:1999-09-02
Applicant: BASF AG
Inventor: KESSEL KNUT DR , SCHERR GUENTER DR , KLUGE MICHAEL DR , BIEDERMANN NORBERT DR , GREINDL THOMAS DR , BOGENSTAETTER THOMAS DR , HAEHNLEIN WOLFGANG DR
IPC: C07C279/14 , C07C277/02 , C07C277/08
Abstract: Preparation of creatine or creatine monohydrate by reaction of sodium or potassium sarcosinate with cyanamide at 20-150 degrees C and pH 7.0 to 14.0, the pH value is obtained using carbonic acid.
-
公开(公告)号:SI0985661T1
公开(公告)日:2002-04-30
申请号:SI9930024
申请日:1999-09-02
Applicant: BASF AG
Inventor: KESSEL KNUT DR , SCHERR GUENTER DR , KLUGE MICHAEL DR , BIEDERMANN NORBERT DR , GREINDL THOMAS DR , BOGENSTAETTER THOMAS DR , HAEHNLEIN WOLFGANG DR
IPC: C07C277/08 , C07C279/14
-
公开(公告)号:DE4120327A1
公开(公告)日:1992-12-24
申请号:DE4120327
申请日:1991-06-20
Applicant: BASF AG
Inventor: SCHMIDT ULRICH PROF DR , GRIESSER HELMUT , HAAS GERHARD DR , KRONER MATTHIAS DR , RIEDL BERND , EMLING FRANZ DR , HAUPT ANDREAS DR , KLUGE MICHAEL DR
Abstract: Described are peptides of formula (I), in which R , R , R , R , R , X and X are as defined in the description, as well as their preparation. The new peptides are suitable for use in the treatment of illnesses.
-
-
-
-
-
-
-